Medical cannabis holds promise to help people with inflammatory skin conditions (WTOP News)

January 21, 2022
Adam Friedman, MD, FAAD

People with skin conditions are open to trying medical cannabis products as potential treatments, according to a study from The George Washington University School of Medicine and Health Sciences and the University of Maryland.

The study, said to be the largest of its kind involving 504 respondents, found that 88.8% support the use of medical cannabis for dermatologic diseases and many already are doing so even without guidance from a dermatologist.

Products available over-the-counter are hemp-derived and made up of CBD or cannabidiol; they have very little or no THC. Both THC and CBD are naturally occurring in cannabis plants but CBD isn’t mind altering and won’t cause a high like THC.

Nearly 18% of those surveyed said they use over-the-counter medical cannabis products, or MCPs, in the form of creams or oil-based products to treat conditions, such as acne, rosacea, atopic dermatitis and psoriasis.

“Given that we know that consumers are already using cannabis-based products without a doctor’s recommendation, it is of the utmost importance that products available over-the-counter have a certain level of quality assurance,” said Dr. Adam Friedman, professor and chair of dermatology at The George Washington University School of Medicine and Health Sciences in D.C.

Read the full article on WTOP news
 

 

Latest News

December 7, 2023
The GW Medical Faculty Associates recently received a gift from Personalized Medicine Care Diagnostics (PMCDx), an advanced molecular diagnostic testing laboratory, in memory of Manny Velasquez, MD, Professor Emeritus of Medicine at GW SMHS and a long-time nephrologist at the GW MFA, who passed…
December 7, 2023
The flu shot is the first line of defense. Help protect yourself and your family against the influenza virus. When it’s flu season, take the necessary steps to stay healthy. That means separating fact from fiction.
November 20, 2023
Division of Renal Disease and Hypertension at GW’s Medical Faculty Associates (GW MFA) was recently selected by Polycystic Kidney Disease Foundation to be a Partner Clinic through the foundation’s autosomal dominant polycystic kidney disease (ADPKD) Centers of Excellence program.